COVID-19 Patient In Pune Recovers After Plasma Therapy: Hospital

Grant Boone
May 24, 2020

"The condition of the patient improved and her repeat tests following the 14-day period came out negative".

Convalescent Plasma Therapy is an experimental procedure where plasma from the blood of a recovered COVID-19 patient is transfused to a critically ill coronavirus patient.

People who survive an infectious disease like COVID-19 are left with blood containing antibodies, or proteins made by the body's immune system to fight off a virus. The blood component that carries the antibodies can be collected and given to newly infected patients - it is known as "convalescent plasma".

Mt. Sinai analysed outcomes for 39 hospitalised patients with severe COVID-19 who received convalescent plasma transfusions compared to outcomes for patients with carefully matched medical status.

The DMCH authorities have urged all recovered patients to donate plasma so that it can be used for the treatment of critically ill Covid-19 patients. "I have recovered ... and fortunately did not have any major symptoms".

After two weeks, the disease worsened in 18 per cent of the plasma patients and 24 per cent of the control patients.

Mika Brzezinski Calls Trump ‘Sick’ For Reviving Conspiracy Theory About Joe Scarborough
Did he get away with murder? Why did he leave Congress so quietly and quickly? Mr Scarborough was in Washington DC at the time. Brzezinski took offense to the president's speculation on whether Scarborough was directly involved in the case.

He and his wife were the first Covid-19 patients reported in the state. "He will be soon discharged from hospital", Sasoon Hospital said.

The plasma was infused in the 47-year-old patient on May 10 and 11 (200 ml each on both days).

Prof Khan, however, warned all, saying plasma therapy is only needed for critical patients in intensive care units (ICUs) and it is not necessary at all for other patients.

On May 16, DMCH began collecting plasma for experimental trials and research with the lack of drug therapies or vaccines for the highly contagious Covid-19.

The DCGI had given the nod for the trial to see if this could be a potential treatment for the infection.

Other reports by

Discuss This Article